We are live on ! Find out more
OCM

Orleans Capital Management Portfolio holdings

AUM $148M
1-Year Est. Return 24.31%
This Fund
S&P 500
This Quarter Est. Return
+3.55%
1 Year Est. Return
+24.31%
3 Year Est. Return
+67.86%
5 Year Est. Return
+100.75%
10 Year Est. Return
+214.87%
AUM
$135M
AUM Growth
+$2.2M
Cap. Flow
-$1.55M
Cap. Flow %
-1.15%
Top 10 Hldgs %
30.18%
Holding
86
New
3
Increased
24
Reduced
32
Closed
6

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$2.77M
2
BA icon
Boeing
BA
+$2.48M
3
O icon
Realty Income
O
+$941K
4
INTC icon
Intel
INTC
+$327K
5
OXY icon
Occidental Petroleum
OXY
+$324K

Sector Composition

Rank Sector Weight
1 Technology 13.25%
2 Financials 11.97%
3 Healthcare 9.76%
4 Consumer Staples 7.86%
5 Utilities 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
76
Vanguard Dividend Appreciation ETF
VIG
$114B
$215K 0.16%
1,800
PHYS icon
77
Sprott Physical Gold
PHYS
$15.6B
$163K 0.12%
13,800
BA icon
78
Boeing
BA
$183B
-6,805
Closed -$2.48M
CME icon
79
CME Group
CME
$95.6B
-1,120
Closed -$217K
CVS icon
80
CVS Health
CVS
$122B
-5,075
Closed -$277K
INTC icon
81
Intel
INTC
$508B
-6,830
Closed -$327K
JNJ icon
82
Johnson & Johnson
JNJ
$618B
-19,883
Closed -$2.77M
XLB icon
83
State Street Materials Select Sector SPDR ETF
XLB
$8.63B
-7,100
Closed -$208K

Similar funds

Orleans Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Orleans Capital Management held 86 positions worth $135M, up 1.7% from $133M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Orleans Capital Management's Q3 2019 filing shows 3 new, 24 increased, 32 reduced and 6 closed positions. Its largest new stake was iShares US Medical Devices ETF: 37,500 shares worth $1.54M. The largest sale was Johnson & Johnson, an estimated $2.77M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Orleans Capital Management's largest Q3 2019 buy was iShares US Medical Devices ETF: 37,500 shares worth $1.54M.
  • Orleans Capital Management added most to Invesco Aerospace & Defense ETF in Q3 2019, an estimated $1.5M increase.
  • Orleans Capital Management's biggest Q3 2019 reduction was Realty Income, cutting an estimated $941K.
  • Orleans Capital Management fully exited Johnson & Johnson in Q3 2019, selling an estimated $2.77M.
  • Orleans Capital Management's ten largest holdings make up 30% of its $135M portfolio in Q3 2019.
  • Orleans Capital Management opened 3 new positions and closed 6 in Q3 2019.
  • Orleans Capital Management's portfolio value rose 1.7% quarter-over-quarter to $135M.

Based on Orleans Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.